首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Hepatology Research

Hepatology Research杂志,由Wiley-Blackwell Publishing Ltd出版,于1997年创刊,Monthly,出版语言English,ISSN:1386-6346,E-ISSN:1872-034X。

投稿咨询
Hepatology Research
Hepatology Research
Hepatology Research
SCI SCIE

杂志介绍

JCR分区
Q2
中科院分区
3区
影响因子
3.7
CiteScore
6.5
期刊收录
SCI、SCIE

Hepatology Research(中文译名:《肝病学研究》),ISSN:1386-6346,EISSN:1872-034X,是Wiley-Blackwell Publishing Ltd出版的国际性学术期刊,创刊于1997年,以Monthly形式稳定发行,2026年总发文量约151篇。该刊采用非OA开放访问,学科归属为医学 - 胃肠肝病学。该刊是医学、胃肠肝病学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达3.7,2025年期刊CiteScore为6.5,2025年期刊自引率约10.8%,在中科院期刊分区体系中位列医学大类3区,在所属学科领域具备高学术影响力与国际认可度。Hepatology Research长期聚焦医学、胃肠肝病学及相关产业的技术应用前沿,平均审稿周期约1.2月,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、胃肠肝病学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,JapanCHINA MAINLAND、USA、England、GERMANY (FED REP GER)、Italy、India等为核心发文国家与地区;HIROSHIMA UNIVERSITYKURUME UNIVERSITY、UNIVERSITY OF TOKYO、OSAKA UNIVERSITY、HOKKAIDO UNIVERSITY、TORANOMON HOSPITAL、KYOTO UNIVERSITY等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学
3区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学
4区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学
3区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:GASTROENTEROLOGY & HEPATOLOGY SCIE Q2 49 / 153

68.3

学科:GASTROENTEROLOGY & HEPATOLOGY SCIE Q2 43 / 153

72.22

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:GASTROENTEROLOGY & HEPATOLOGY SCIE Q2 47 / 148

68.6

学科:GASTROENTEROLOGY & HEPATOLOGY SCIE Q1 31 / 148

79.39


中国学者近期发文

1
The Microbiome-Gut-Liver Axis Drives Post-Kasai Fibrosis in Biliary Atresia: From Mechanism to Precision Interventio

Author:Cheng, Jiwen

Journal: HEPATOLOGY RESEARCH. 2026; Vol. , Issue , pp. -. DOI: 10.1111/hepr.70184

2
Lenvatinib Promotes Metabolic Reprogramming Through RTK to Inhibit Hepatocellular Carcinoma Proliferation and Metastasi

Author:Zhao, Xiaofang; Yan, Shengxiang; Meng, Jing; Wang, Limin

Journal: HEPATOLOGY RESEARCH. 2026; Vol. , Issue , pp. -. DOI: 10.1111/hepr.70164

3
Comment on Using Serum Creatinine-to-Cystatin C Ratio to Predict Sarcopenia in Patients With Liver Cirrhosi

Author:Wang, Weiming; Wang, Miaofeng; Tang, Lifeng

Journal: HEPATOLOGY RESEARCH. 2026; Vol. , Issue , pp. -. DOI: 10.1111/hepr.70183

4
Letter to the Editor: Lymphocyte-Monocyte Ratio Predicts Survival in Patients With Unresectable Hepatocellular Carcinoma Treated With Durvalumab Plus Tremelimumab: A Multicenter Analysi

Author:Jiang, Chengli

Journal: HEPATOLOGY RESEARCH. 2026; Vol. , Issue , pp. -. DOI: 10.1111/hepr.70144

5
Comment on Effect of Direct-Acting Antivirals on Prognosis in Older Patients With Hepatitis C Virus-Related Hepatocellular Carcinoma After Curative Therapy: A Retrospective Study by the Red Cross Liver Study Group in Japa

Author:Jin, Haonan

Journal: HEPATOLOGY RESEARCH. 2026; Vol. , Issue , pp. -. DOI: 10.1111/hepr.70145

6
Letter to the Editor: Effect of Direct-Acting Antivirals on Prognosis in Older Patients With Hepatitis C Virus-Related Hepatocellular Carcinoma After Curative Therapy: A Retrospective Study by the Red Cross Liver Study Group in Japa

Author:Ke, Haigu; Shi, Wenwen; Sheng, Minhui

Journal: HEPATOLOGY RESEARCH. 2026; Vol. , Issue , pp. -. DOI: 10.1111/hepr.70154

7
Associations of serum carotenoids with cardiovascular disease mortality among patients with metabolic dysfunction-associated steatotic liver diseas

Author:Wang, Qian-Qian; Zhu, Jing; Miao, Lin-Jun; Lv, Si-Ang; Shen, Guo-Yin; Wu, Jun

Journal: HEPATOLOGY RESEARCH. 2025; Vol. , Issue , pp. -. DOI: 10.1111/hepr.14215

8
CXCL6 Is a Novel Biliary Marker and a Downstream Target of MMP7 in Biliary Atresi

Author:Kong, Fanyang; Jiang, Jingying; Du, Min; Dong, Rui; Chen, Gong; Zheng, Shan; Wang, Junfeng

Journal: HEPATOLOGY RESEARCH. 2025; Vol. , Issue , pp. -. DOI: 10.1111/hepr.14217

9
Adjuvant Transarterial Chemoembolization After Truly Curative Resection Does Not Improve Survival of Patients With Hepatocellular Carcinoma at High Risk of Recurrence: A Target Trial Emulation Stud

Author:Su, Jia-Yong; Huang, De-Jia; Liu, Shao-Ping; Xu, Xiao-Ling; Chen, Shu-Chang; Ou, Jun-Jie; Li, Jian-Rong; Yang, Tai-Xin; Li, Wen-Yang; Fan, Yuan; Wen, Zhao-Chan; Chen, Le; Qin, Zhen; Long, Bei-Bei; Li, Da-Zhi; Huang, Jiang-Hong; Lu, Yi-Jia; Zhong, Jun-Chi; Zhu, Hai-Qiang; Ma, Liang; Liang, Xiu-Mei; Zhong, Jian-Hong

Journal: HEPATOLOGY RESEARCH. 2025; Vol. , Issue , pp. -. DOI: 10.1111/hepr.14219

10
Beyond Biochemical Response: Rethinking Risk Stratification and Endpoint Hierarchy in PB

Author:Li, Yadi; Wei, Zheng; Deng, Xinmin

Journal: HEPATOLOGY RESEARCH. 2025; Vol. , Issue , pp. -. DOI: 10.1111/hepr.14230


在线咨询

Hepatology Research

国际简称:HEPATOL RES参考译名:肝病学研究

年发文量:151 CiteScore:6.5 是否预警:否 Gold OA文章占比:28.57% 研究类文章占比:95.36%

杂志社联系方式:WILEY-BLACKWELL PUBLISHING, INC, COMMERCE PLACE, 350 MAIN ST, MALDEN, USA, MA, 02148

Hepatology Research